SCHEMBL8287394

SCHEMBL8287394

Cc1cc(C(=O)Nc2ccccc2Cl)nc2c1c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.42
NR3C1 P04150 1/20 0.41
MAPK8 P45983 2/20 0.41
MAPK10 P53779 2/20 0.41
MAPK9 P45984 1/20 0.41
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
POLB P06746 2/20 0.40
LMNA P02545 1/20 0.40
RIPK1 Q13546 1/20 0.40
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
KDM4E B2RXH2 3/20 0.40
MAPT P10636 3/20 0.40
GAA P10253 1/20 0.40
MAPK1 P28482 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
ALDH1A1 P00352 2/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287393 0.91 PDE11A (0.46) PDE11ANR3C1POLBLMNARIPK1
SCHEMBL8287388 0.88 MAPT (0.48) PDE11ANR3C1KMT2AMEN1LMNA
SCHEMBL8287516 0.87 RIPK1 (0.50) PDE11ANR3C1KMT2AMEN1POLB
SCHEMBL5872175 0.87 PDE11A (0.47) PDE11APOLBLMNAKDM4EMAPT
SCHEMBL5871541 0.86 PDE11A (0.46) PDE11APOLBLMNANPC1RAB9A
SCHEMBL8287397 0.85 PDE11A (0.46) PDE11APOLBLMNANPC1RAB9A
SCHEMBL8286396 0.84 PDE11A (0.44) PDE11AMAPK8MAPK10MAPK9POLB
SCHEMBL8286399 0.84 PDE11A (0.46) PDE11APOLBRIPK1NPC1RAB9A
SCHEMBL8285169 0.84 PDE11A (0.45) PDE11AKMT2AMEN1POLBLMNA
SCHEMBL8285205 0.83 MAPT (0.44) PDE11AKMT2AMEN1LMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed